reac-technology
Contact us
reac-technology
Contact us

REAC® Technology: Why It Is Not a Symptomatic Therapy

Discover why REAC® Technology isn’t just a symptomatic therapy. Learn how bioelectric modulation optimizes biological processes for lasting functional results.

  • March 13, 2026
reac-technology-functional-optimization

Imagine you are driving and a red warning light flashes on your dashboard. You have two options: cover the light with black tape so you don’t have to see it anymore, or open the hood and find out why the engine is malfunctioning.

In modern medicine, something very similar often happens. Many therapies act like that piece of tape: they hide the symptom without addressing the cause. In this post, we explore why REAC® Technology chooses the second path, defining itself not as a symptomatic therapy, but as a functional optimization therapy.

The Symptom is Not the Enemy

Whether it is pain, anxiety, stiffness, or inflammation, a symptom is actually a signal. It tells us that our organism is trying to adapt to a difficult situation, but it is doing so inefficiently. This is what we call a dysfunctional adaptation.

While analgesic or anti-inflammatory drugs are useful in emergencies to block the signal, they do not change how the body functions.

Working on the Submerged Part of the Iceberg

REAC® Technology works differently. Through bioelectric modulation, it acts on what we can describe as the “submerged part of the iceberg”. Its goal is to help the brain and tissues reorganize and regain their biological efficiency.

When the organism starts functioning efficiently again:

  • The symptom disappears naturally.
  • It is not “masked”; rather, the confusion that generated it is resolved.

Practical Examples: Pain and Inflammation

  1. Chronic Pain: It often does not stem from an acute injury, but from a nervous system that remains “stuck” in a state of alarm. REAC optimizes brain activity so that the brain stops sending that erroneous alarm signal.
  2. Persistent Inflammation: Instead of forcing the inflammation to shut down with chemicals, REAC biomodulation protocols restore the natural electric currents of the cells, allowing them to complete the healing process that had stalled.

Stable and Lasting Results

Choosing a functional optimization approach means more than just asking the body to “stop complaining.” We help it solve the underlying problem. For this reason, results achieved with REAC® Technology tend to be more stable over time: they are the outcome of a true biological change rather than a temporary chemical effect.

Watch the full video here:

Did you find this article interesting? Share it!

Subscribe to the newsletter

reac-technology
Home About News
Contact us
© 2026 REAC® All rights reserved
Privacy Policy Terms of Use and Legal Notice
Manage Cookie Credits

Dr. Vania Fontani

dr-vania-fontani-rinaldi-fontani-institute

Dr. Vania Fontani MD, PhD, is a prominent figure in the field of regenerative medicine and neurobiological modulation.

She has dedicated her career to research and the development of innovative technologies for human well-being.

Currently, Dr. Fontani holds the position of Scientific Director at the Rinaldi Fontani Institute in Florence, where she leads the Department of Regenerative Medicine.

In collaboration with Prof. Salvatore Rinaldi, she co-developed the REAC® (Radio Electric Asymmetric Conveyer) technology, a non-invasive methodology aimed at modulating endogenous bioelectric activity to promote health and well-being.

Her research work is documented in over 60 scientific publications, with a significant impact in the field of neuromodulation and regenerative medicine.
Her experience and expertise make her an ideal speaker for international events focused on innovation and longevity

Learn more:
• Publications: PubMed – Rinaldi S, Fontani V

Prof. Salvatore Rinaldi

dr-salvatore-rinaldi-rinaldi-fontani-institu

Physician and researcher, pioneer in neurobiological modulation, regenerative medicine, and anti-senescence therapies Scientific Director – Rinaldi Fontani Institute, Florence, Italy
ORCID: 0000-0002-8961-6316

Profile and Mission

Salvatore Rinaldi is an internationally recognized innovator for his groundbreaking
contribution to the study and clinical application of neurobiological modulation using
asymmetrically conveyed radio-electric signals (REAC). His work has redefined the
boundaries of regenerative medicine and longevity, demonstrating how optimizing
endogenous bioelectrical activity can promote cellular reprogramming, recovery of
compromised functions, and the prevention of age-related decline.

 

Research Milestones

Rinaldi’s research has opened new frontiers in the understanding and treatment of
neurodegenerative diseases and cellular aging processes. Among his most significant
contributions:


Regenerative Medicine:

  • Direct cellular reprogramming through epigenetic modulation of
    endogenous bioelectrical activity with REAC technology.
  • Radiofrequency energy loop primes cardiac, neuronal, and skeletal muscle
    differentiation in mouse embryonic stem cells: a new tool for improving tissue
    regeneration. Cell Transplant. 2012;21(6):1225-33. doi: 10.3727/096368911X600966.
  • Radio electric conveyed fields directly reprogram human dermal skin fibroblasts
    toward cardiac, neuronal, and skeletal muscle-like lineages. Cell Transplant.
    2013;22(7):1227-35. doi: 10.3727/096368912X657297.
  • Neurological morphofunctional differentiation induced by REAC technology in PC12. A
    neuro protective model for Parkinson's disease. Sci Rep. 2015 May 15:5:10439. doi:
    10.1038/srep10439.

Anti-Senescence and Longevity:

  • REAC technology and hyaluron synthase 2, an interesting network to slow down stem
    cell senescence. Sci Rep. 2016 Jun 24:6:28682. doi: 10.1038/srep28682.
  • Stem cell senescence. Effects of REAC technology on telomerase-independent and
    telomerase-dependent pathways. Sci Rep. 2014 Sep 16:4:6373. doi:
    10.1038/srep06373.
  • Anti-senescence efficacy of radio-electric asymmetric conveyer technology. Age
    (Dordr). 2014 Feb;36(1):9-20. doi: 10.1007/s11357-013-9537-8.

Neurodegenerative Diseases – Efficacy of REAC Technology in Alzheimer’s and
Neurodegeneration Models:

  • REAC technology modifies pathological neuroinflammation and motor behaviour in an
    Alzheimer's disease mouse model. Sci Rep. 2016 Oct 24:6:35719. doi:
    10.1038/srep35719.
  • Radio Electric Asymmetric Conveyer Technology Modulates Neuroinflammation in a
    Mouse Model of Neurodegeneration. Neurosci Bull. 2018 Apr;34(2):270-282. doi:
    10.1007/s12264-017-0188-0

Scientific Vision

Salvatore Rinaldi’s work demonstrates that bioelectrical modulation is not merely a
theoretical concept, but a concrete and reproducible therapeutic strategy to counteract
aging, support cellular repair processes, and prevent tissue degeneration.

Learn more:
• ORCID Profile: 0000-0002-8961-6316
• Publications: PubMed – Rinaldi S, Fontani V